MAPK1 and prostate carcinoma: This study also reported that PI3KC2β regulates MAPK signaling to mediate prostate cancer cell invasion, thus the PI3KC2β-MEK-ERK signaling axis may present a novel therapeutic target for invasive prostate cancer [81].